Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

DICE Therapeutics Q3 EPS $(0.55) Up From $(2.15) YoY

DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.55) per share. This is a 74.42 percent increase over losses of $(2.15) per share from the same period last year.
byBill Haddad
November 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.55) per share. This is a 74.42 percent increase over losses of $(2.15) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts